Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2009 - 2026)
Dr Reddys Laboratories' Other Accumulated Expenses came in at $441.79 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 16.2% from $527.2 million a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Other Accumulated Expenses was $537 million, up 0.8% from FY2025.
- Other Accumulated Expenses has increased in each of the last 11 fiscal years, with a five-year compound annual growth rate of 5.2% (FY2021 to FY2026).
- Going back by fiscal year, Other Accumulated Expenses was $533 million in FY2025 (+3.5%), $515 million in FY2024 (+7.3%), $480 million in FY2023 (+7.1%) and $448 million in FY2022 (+7.4%).
- The fiscal Q2 2027 figure represents the lowest quarterly Other Accumulated Expenses since fiscal Q1 2025.
- Year-over-year, Other Accumulated Expenses increased in six of the last eight quarters, with growth averaging 1.0%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in fiscal Q1 2026 (growth of 17.3%), and the weakest in fiscal Q2 2027 (a decline of 16.2%).
- Business Quant data shows RDY's Other Accumulated Expenses at $459.16 million (Q1 2027), $532.65 million (Q4 2026) and $512.96 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 441.79 Mn |
| Jun 30, 2026 | 459.16 Mn |
| Mar 31, 2026 | 532.65 Mn |
| Dec 31, 2025 | 512.96 Mn |
| Sep 30, 2025 | 527.20 Mn |
| Jun 30, 2025 | 512.28 Mn |
| Mar 31, 2025 | 531.75 Mn |
| Dec 31, 2024 | 489.87 Mn |
| Sep 30, 2024 | 499.51 Mn |
| Jun 30, 2024 | 436.87 Mn |
| Mar 31, 2024 | 514.40 Mn |
| Dec 31, 2023 | 473.49 Mn |
| Sep 30, 2023 | 441.68 Mn |
| Jun 30, 2023 | 433.64 Mn |
| Mar 31, 2023 | 480.78 Mn |
| Dec 31, 2022 | 419.30 Mn |
| Sep 30, 2022 | 408.83 Mn |
| Jun 30, 2022 | 418.20 Mn |
| Mar 31, 2022 | 448.28 Mn |
| Dec 31, 2021 | 420.62 Mn |
API Access
Dr Reddys Laboratories Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();